Bernard Linsmeau

Pharmacist from UCLouvain and MBA from the Louvain School of Management, with corporate finance at IE Madrid. Thirty of thirty-five working years in the health industry, at Novartis, GSK Vaccines and now Okapi Consult, and more than twenty-one of them in business development.

Okapi Consult, since September 2022

Founder and director. Biopharma senior advisor to Belgian and international companies, in corporate business development: strategic partnerships, technology transfer, in- and out-licensing, acquisitions, mergers and divestitures of products, sites and entities. Currently Chief Business Development Officer at Bio-Sourcing and senior BD advisor at Osivax; previously Director Business Development and Growth at BioWin, the health cluster of Wallonia.

GSK Vaccines, 2000 to 2021

Head of Worldwide Strategic Ventures and Alliances from 2015, reporting to the Vaccines executive team, leading global business development in the commercial and manufacturing domains with a team of directors across Belgium, Italy and the United States. Before that, Director Business Development and Strategic Alliances from 2006, and earlier roles in customer services and worldwide manufacturing planning.

Before that

Logistics director at PolyOne, senior consultant and project manager at PwC on assignments for Exxon, GE, Arcelor, Warner-Lambert and Nestlé, and finance and logistics roles at Novartis and Ciba-Geigy.